A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services

British Journal of Cancer

Volumn 95, Issue 10, 2006, Pages 1448-1453

  Peacock, S ^a,b   Apicella, C ^c   Andrews, L ^d   Tucker, K ^d   Bankier, A ^e   Daly, M B ^f   Hopper, J L ^c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f FOX CHASE CANCER CENTER   (United States)

Author keywords

Ashkenazi; BRCA1 and BRCA2; Breast cancer; Client preferences; Discrete choice experiment; Genetic counselling

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER RISK; CONTROLLED STUDY; DECISION MAKING; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; JEW; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CHOICE BEHAVIOR; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; ISRAEL; JEWS; MIDDLE AGED;

EID: 33751026374     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603451     Document Type: Article

References (38)

1. Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL (2003) Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res 5: R206-R216, doi:10. 1186/bcr644
2. Apicella C, Peacock S, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL (2006) Determinants of preferences for genetic counselling in Jewish Women. Fam Cancer 5: 159-167, doi:10.1007/s10689-005-3871-7
3. Berkenstadt M, Shiloh S, Barkai G, Katznelson MB, Goldman B (1999) Perceived personal control (PPC): a new concept in measuring outcome of genetic counseling. Am J Med Genet 82: 53-59, doi:10.1002/(SICI)1096-8628(19990101)82:1
4. Bernhardt BA, Biesecker BB, Mastromarino CL (2000) Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment. Am J Med Genet 94: 189-197
5. Bradley M (1991) User's Manual for SPEED Version 2.1 Stated Preference Experiment Editor and Designer. Hague: Hague Consulting Group
6. Brain K, Gray J, Norman P, France E, Anglim C, Barton G, Parsons E, Clarke A, Sweetland H, Tischkowitz M, Myring J, Stansfield K, Webster D, Gower-Thomas K, Daoud R, Gateley C, Monypenny I, Singhal H, Branston L, Sampson J, Roberts E, Newcombe R, Cohen D, Rogers C, Mansel R, Harper P (2000) Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst 92: 1345-1351
7. Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J (2001) Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing. Qual Life Res 10: 595-607, doi:10.1023/A:1013123915272
8. Clarke A, Parsons E, Williams A (1996) Outcomes and process in genetic counselling. Clin Genet 50: 462-469
9. Cohn WF, Ropka ME, Jones SM, Miesfeldt S (2003) Information needs about hereditary breast cancer among women with early-onset breast cancer. Can Detect Prev 27: 345-352, doi:10.1016/j.cdp.2003.07.001
10. Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, Brower ST, Eng CM (1998) Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63: 45-51
11. Genetic Interest Group (1998) Guidelines for Genetics Services. A Working Party Report. London: GIG
12. Hallowell N, Murton F, Statham H, Green JM, Richards MP (1997) Women's need for information before attending genetic counselling for familial breast or ovarian cancer: a questionnaire, interview, and observational study. BMJ 314: 281-283
13. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64: 963-970
14. Holloway S, Porteous M, Cetnarskyj R, Anderson E, Rush R, Fry A, Gorman D, Steel M, Campbell H (2004) Patient satisfaction with two different models of cancer genetic services in south-east Scotland. Br J Cancer 90: 582-589, doi:10:1038/sjbjc6601562
15. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D, Breast Cancer Family Registry (2004) Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 6: R375-R389, Epub 2004 May 19, doi:10.1196/bcr901
16. Lloyd AJ (2003) Threats to the estimation of benefit: are preference elicitation methods accurate? Health Econ 12: 393-402, doi:10.1002/nec.772
17. Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 37: 866-874
18. Pieterse A, van Dulmen S, Ausems M, Schoemaker A, Beemer F, Bensing J (2005a) QUOTE-gene(ca): development of a counselee-centered instrument to measure needs and preferences in genetic counseling for hereditary cancer. Psycho-oncology 14: 361-375
19. Pieterse AH, Ausems MG, Van Dulmen AM, Beemer FA, Bensing JM (2005b) Initial cancer genetic counseling consultation: change in counselees' cognitions and anxiety, and association with addressing their needs and preferences. Am J Med Genet 137A: 27-35
20. Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K (1997) Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test 1: 47-51
21. Royal College of Physicians (1998) Commissioning Clinical Genetics Services. London: Royal College of Physicians
22. Ryan M (1999) Using conjoint analysis to go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 48: 535-546, doi:10.1016/SO277-9536(98)00374-8
23. Ryan M (2004) Discrete choice experiments in health care. BMJ 328: 360-361, doi:10.11361/bmj.328.7436.360
24. Ryan M, Farrar S (2000) Using conjoint analysis to elicit preferences for health care. BMJ 320: 1530-1533, doi:10.1136/bmj.320.7248.1530
25. Ryan M, Gerard K (2002) Using discrete choice experiments in health economics: moving forward. In Advances in Health Economics Scott A, Maynard A, Elliott R (eds) pp 25-40. Chichester: Wiley
26. Ryan M, Gerard K (2003) Using discrete choice experiments to value health care: current practice and future prospects. Appl Health Econ Policy Analysis 2: 55-64
27. Ryan M, Watson V, Amaya-Amaya M (2003) Methodological issues in the monetary valuation of benefits in health care. Exp Rev Pharmacoecon Outcomes Res 3: 717-727
28. Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, Karp SE, Begg CB (2001) The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomark Prevent 10: 467-473
29. Scott A (2002) Identifying and analysing dominant preferences in discrete choice experiments: an application in health care. J Econ Psyc 23: 383-398, doi:10.1016/SO167-4870(02)00082-X
30. Sculpher M, Bryan S, Fry P, de Winter P, Payne H, Emberton M (2004) Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ 328: 382-385, doi:10.1136/bmj.37972.497234.44
31. Shiloh S, Avdor O, Goodman RM (1990) Satisfaction with genetic counseling: dimensions and measurement. Am J Med Genet 37: 522-529
32. Stadler MP, Mulvihill JJ (1998) Cancer risk assessment and genetic counseling in an academic medical center: consultands' satisfaction, knowledge, and behaviour in the first year. J Genet Couns 7: 279-297
33. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
34. Thompson JA, Wiesner GL, Sellers TA, Vachon C, Ahrens M, Potter JD, Sumpmann M, Kersey J (1995) Genetic services for familial cancer patients: a survey of National Cancer Institute cancer centers. J Natl Cancer Inst 87: 1446-1455
35. Tiller K, Meiser B, Gould L, Tucker K, Dudding T, Franklin J, Friedlander M, Andrews L (2005) Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Psycho-Oncol 14: 249-261, doi: 10.1002/pon.840
36. Ubach C, Scott A, French F, Awramenko M, Needham G (2003) What do hospital consultants value about their jobs? A discrete choice experiment. BMJ 326: 1432-1442, doi:10.1136/bmj.326.7404.1432
37. Viney R, Lancsar E, Louviere J (2002) Discrete choice experiments to measure preferences for health and health care. Exp Rev Pharmacoecon Outcomes Res 2: 319-326
38. Wilson B, Ryan M, Haites N (2000) Assessing User Preferences for, and Costs of, Genetic Counselling for Familial Cancer Risk in Scotland: A Cost-Utility Analysis Using Conjoint Analysis. Scottish: Report to the Chief Scientist Office, Executive Health Department